Sign in
  • USA
  • UK
  • Germany
  • France
  • Canada
  • India
  • Italy
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
LogoFinSMEs The Website About Venture Capital News
LogoFinSMEs The Website About Venture Capital News
  • USA
  • UK
  • Germany
  • France
  • Canada
  • India
  • Italy
Home Tags OrbiMed

Tag: OrbiMed

healthcare
USA

ArriVent Biopharma Closes $155M in Series B Financing

FinSMEs -
March 27, 2023
0
healthcare
Canada

Congruence Therapeutics Closes Extension Funding; Closes Over US$65M Series A

FinSMEs -
March 6, 2023
0
TANDEMAI
China

TandemAI Raises $35M in Series A Financing

FinSMEs -
March 1, 2023
0
Pathalys Pharma
USA

Pathalys Pharma Raises $150M in Secured Product Financing and Equity

FinSMEs -
January 20, 2023
0
Amolyt Pharma
France

Amolyt Pharma Raises $138M inĀ Series C Financing

FinSMEs -
January 9, 2023
0
pic-therapeutics
USA

PIC Therapeutics Closes $35M Series A Financing

FinSMEs -
October 20, 2022
0
Odyssey Therapeutics
USA

Odyssey Therapeutics Raises $168M in Series B Financing

FinSMEs -
October 13, 2022
0
acelyrin Logo
USA

Acelyrin Raises $300M Series C Financing

FinSMEs -
September 13, 2022
0
frontera therapeutics
China

Frontera Therapeutics Closes $160M Series B Financing

FinSMEs -
July 20, 2022
0
Delfi Diagnostics Announces $225 Million Series B Financing
USA

Delfi Diagnostics Raises $225M in Series B Financing

FinSMEs -
July 18, 2022
0
Upstream_logo
USA

Upstream Bio Raises $200M in Series A Financing

FinSMEs -
June 2, 2022
0
Damien McDevitt
USA

Aspen Neuroscience Raises $147.5M in Series B Financing

FinSMEs -
May 9, 2022
0
sionna
USA

Sionna Therapeutics Raises $111M in Series B Financing

FinSMEs -
April 21, 2022
0
MDClone
Israel

MDClone Raises $63M in Series C Funding

FinSMEs -
March 1, 2022
0
Electra_Therapeutics_logo
USA

Electra Therapeutics Raises $84M in Series B Financing

FinSMEs -
February 17, 2022
0
1234...14Page 3 of 14
  • Contact
  • About
  • Privacy Policy
  • Advertise with Us
  • Disclaimer
  • GDPR
  • Terms & Conditions

Follow Us

Twitter